Deltex Medical Group Plc

  • Market Cap: Micro Cap
  • Industry: Medical Specialties
  • ISIN: GB0059337583
GBP
0.00
0 (-50.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

272.37 M

Shareholding (Dec 2021)

FII

5.53%

Held by 1 FIIs

DII

0

Held by 0 DIIs

Promoter

18.32%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Flat results in Jun 24

  • OPERATING CASH FLOW(Y) Lowest at GBP -1.57 MM
  • ROCE(HY) Lowest at -52.72%
  • RAW MATERIAL COST(Y) Grown by 18.24% (YoY)
2

Risky - Not traded in last 10 days

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Medical Specialties

stock-summary
Market cap

GBP 0 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.55

stock-summary
Return on Equity

-32.63%

stock-summary
Price to Book

0.16

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-75.0%
0%
-75.0%
6 Months
-85.71%
0%
-85.71%
1 Year
-85.71%
0%
-85.71%
2 Years
-98.26%
0%
-98.26%
3 Years
-98.52%
0%
-98.52%
4 Years
-99.09%
0%
-99.09%
5 Years
-98.48%
0%
-98.48%

Deltex Medical Group Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-17.37%
EBIT Growth (5y)
-24.21%
EBIT to Interest (avg)
-0.86
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.55
Sales to Capital Employed (avg)
0.63
Tax Ratio
3.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.16
EV to EBIT
-2.02
EV to EBITDA
-2.03
EV to Capital Employed
0.46
EV to Sales
1.14
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-19.14%
ROE (Latest)
-32.63%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
Bullish
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2021stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (5.53%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Deltex Medical Group Plc"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -28.00% vs 8.70% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -18.18% vs -10.00% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.80",
          "val2": "2.50",
          "chgp": "-28.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.80",
          "val2": "-0.90",
          "chgp": "11.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.30",
          "val2": "-1.10",
          "chgp": "-18.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-523.10%",
          "val2": "-422.20%",
          "chgp": "-10.09%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
1.80
2.50
-28.00%
Operating Profit (PBDIT) excl Other Income
-0.80
-0.90
11.11%
Interest
0.20
0.20
Exceptional Items
-0.30
0.00
Consolidate Net Profit
-1.30
-1.10
-18.18%
Operating Profit Margin (Excl OI)
-523.10%
-422.20%
-10.09%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is -28.00% vs 8.70% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -18.18% vs -10.00% in Dec 2022

stock-summaryCompany CV
About Deltex Medical Group Plc stock-summary
stock-summary
Deltex Medical Group Plc
Medical Specialties
Deltex Medical Group plc is a United Kingdom-based haemodynamic management company, which manufactures fluid management devices. The Company's segments are Probes and Other. The Company's Esophageal Doppler Simulator (EDS) enables clinicians to practice probe insertion, focussing and waveform interpretation outside of a patient setting. The Company's CardioQ-EDM and CardioQ-EDM+ esophageal Doppler monitors (EDM) are designed to allow clinicians to guide fluid and drug administration during surgery. The Company's oesophageal Doppler haemodynamic monitoring (ODM) uses ultrasound to measure blood flows in the central circulation of patients, and allows doctors to fine tune the circulation. Its probes include surgical probes, such as I2S and I2P, and critical care probes, such as I2C and EDP240. Its I2S and I2P are used in patients who are anesthetized, sedated or awake. Its EDP240 is used in patients under anesthesia or full sedation. It has operations in Spain and Canada, among others.
Company Coordinates stock-summary
Company Details
Terminus Road , CHICHESTER None : PO19 8TX
stock-summary
Tel: 44 1243 774837
stock-summary
Registrar Details